etectRx

etectRx is a Health Care startup founded in 2009. The company's slogan, "etectRx’s FDA-cleared ID-Cap™ System is revolutionizing remote patient monitoring through real-time ingestion event data," encapsulates its mission. etectRx has developed the ID-Cap™ System, an ingestible event marker cleared by the FDA that enables real-time, dose-level ingestion event verification. This patented system has garnered attention from various stakeholders including patients, healthcare providers, health systems, payers, and research organizations, as it facilitates tracking, measurement, monitoring, and improvement of medication adherence. Notably, it can also be utilized by pharmaceutical companies to develop Digital Medicine. The ID-Cap System, comprising the ID-Capsule containing the ingestible sensor, the ID-Tag, a wearable ID-Cap Reader, and related software for data display, leverages proprietary in vivo communications technology. This technology emits low power radio frequency (RF) digital messages from within the patient, which are then detected using the wearable Reader. With 14 IRB-approved clinical trials already completed, including three NIH-sponsored trials, involving over 5,100 ingestions and 257 participants, etectRx has validated the feasibility, effectiveness, and safety of its innovative technology. As of now, there is no specific information available regarding the last investment and the involved investors. Located in the United States, etectRx stands at the forefront of digital health, offering a promising solution that has the potential to transform remote patient monitoring and medication adherence.